Journal
HEPATOLOGY RESEARCH
Volume 41, Issue 11, Pages 1057-1065Publisher
WILEY-BLACKWELL
DOI: 10.1111/j.1872-034X.2011.00849.x
Keywords
efficacy; hyperlipoproteinemia type IIb; non-alcoholic steatohepatitis with dyslipidemia; pitavastatin; treatment
Categories
Funding
- Grants-in-Aid for Scientific Research [22590747] Funding Source: KAKEN
Ask authors/readers for more resources
Aim: Non-alcoholic fatty liver disease (NAFLD) that encompasses a spectrum of liver disorders characterized by simple steatosis, non-alcoholic steatohepatitis (NASH) through cirrhosis, is becoming an important chronic liver disease in Japan. Currently, there is no proven therapy for NASH. In this study, we assessed the efficacy of statin therapy in NASH patients with dyslipidemia.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
